Yet, other studies discovered that inhibition of EGFR signalling by Erlotinib induced NF-κB through NOX4 in HNSCC.36,37 It remains unclear whether NOX4 can mediate IKK activation in HNSCC. This evidence concerns the gene NFKB1 and head and neck squamous cell carcinoma.